Magnetic Resonance Imaging (MRI) to Assess Radial Artery Compression and Arterial Perfusion While TR Band is Applied
1 other identifier
interventional
4
0 countries
N/A
Brief Summary
Subjects' radial artery diameters and plethysmography waveforms will be recorded by MRI and pulse oxymetry at varying levels of radial artery compression by the Terumo TR Band.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2015
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 19, 2015
CompletedStudy Start
First participant enrolled
June 1, 2015
CompletedFirst Posted
Study publicly available on registry
June 23, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2015
CompletedResults Posted
Study results publicly available
March 24, 2016
CompletedMarch 24, 2016
February 1, 2016
1 month
May 19, 2015
November 30, 2015
February 24, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
MRI Based Radial Artery Measurement
Each subject's radial artery will be measured using MRI at varying levels of pressure within the TR Band.
Subjects will be followed up to one week post procedure
Secondary Outcomes (1)
Hand Perfusion as Measured by Pulse Oxymetry Waveform
Subjects will be followed up to one week post procedure
Study Arms (1)
TR Band
EXPERIMENTALEach subject will have a Terumo TR Band applied to the wrist with MRI scans done at differing band pressure levels. The diameter of the radial artery will be measured at each level of band compression.
Interventions
The radial artery will be compressed using a Terumo TR Band and artery diameter and perfusion will be measured
Eligibility Criteria
You may qualify if:
- Female or male adult (has reached the legal majority age).
- Subject has provided his/her written informed consent to participate in the trial prior to any study -related procedure being conducted.
You may not qualify if:
- Abnormal result of either baseline Barbeau or reverse Barbeau tests.
- Pregnant or breast feeding female.
- Subject with contraindication to MRI
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Terumo Medical Corporationlead
- Medical University of South Carolinacollaborator
Limitations and Caveats
Single center study with small sample size.
Results Point of Contact
- Title
- Robert Gash, Director of Clinical Affairs
- Organization
- Terumo Medical Corporation
Study Officials
- PRINCIPAL INVESTIGATOR
Marcelo Guimaraes, MD
Medical University of South Carolina
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- OTHER
- Restrictive Agreement
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 19, 2015
First Posted
June 23, 2015
Study Start
June 1, 2015
Primary Completion
July 1, 2015
Study Completion
August 1, 2015
Last Updated
March 24, 2016
Results First Posted
March 24, 2016
Record last verified: 2016-02
Data Sharing
- IPD Sharing
- Will not share